Cite

HARVARD Citation

    Li, H. et al. (2019). Small molecule inhibitor agerafenib effectively suppresses neuroblastoma tumor growth in mouse models via inhibiting ERK MAPK signaling. Cancer letters. pp. 129-141. [Online]. 
  
Back to record